6
Views
10
CrossRef citations to date
0
Altmetric
LetterToEditor Article

Ribavirin: A Possible Alternative for the Treatment of Chronic Non-A, Non-B Hepatitis

&
Page 509 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

Nobuyuki Kato. (2020) Hepatitis C virus (HCV) : Development of anti-HCV agents and anti-HCV therapyC型肝炎ウイルス(HCV):抗 HCV 剤の開発と抗 HCV 療法. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 132:3, pages 131-143.
Crossref
O.L. Bryan-Marrugo, J. Ramos-Jiménez, H. Barrera-Saldaña, A. Rojas-Martínez, R. Vidaltamayo & A.M. Rivas-Estilla. (2015) History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C. Medicina Universitaria 17:68, pages 165-174.
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. (2010) Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. (2009) Ribavirin monotherapy for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Jesper Brok, Lise L Gluud & Christian Gluud. (2006) Ribavirin Monotherapy for Chronic Hepatitis C Infection: A Cochrane Hepato-Biliary Group Systematic Review and Meta-Analysis of Randomized Trials. The American Journal of Gastroenterology 101:4, pages 842-847.
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jesper Brok, Lise Lotte Gluud & Christian Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lise Lotte Gluud, Kim Krogsgaard & Christian Gluud. (2002) Ribavirin with or without alpha interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
A. Gruber, H. Norder, L. Magnius, M. Rotzén, C. Rubio, L. Grillner & M. Björkholm. (1993) Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders. Annals of Oncology 4:3, pages 229-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.